key: cord-0722932-fdzvqn2e authors: Aykac, Kubra; Ozsurekci, Yasemin; Yayla, Burcu Ceylan Cura; Gurlevik, Sibel Lacinel; Oygar, Pembe Derin; Bolu, Nuriye Boduc; Tasar, Medine Aysin; Erdinc, Fatma Sebnem; Ertem, Gulay Tuncer; Neselioglu, Salim; Erel, Ozcan; Cengiz, Ali Bülent; Ceyhan, Mehmet title: Oxidant and antioxidant balance in patients with COVID‐19 date: 2021-07-15 journal: Pediatr Pulmonol DOI: 10.1002/ppul.25549 sha: 8b916e0bbf0a140c96c73415c5e460b6c226f7fa doc_id: 722932 cord_uid: fdzvqn2e BACKGROUND: A crucial balance exists between oxidant and antioxidant mechanisms in the functional immune system. We aimed to evaluate the contributions of balance between these systems to coronavirus disease 2019 (COVID‐19), a devastating pandemic caused by viral infection. METHOD: We analyzed serum oxidant and antioxidant stress parameters according to the clinical and demographic characteristics of children and adults with COVID‐19 and compared them against the values of healthy controls. Serum native thiol (NT), total thiol (TT), disulfide, total antioxidant status, total oxidant status, and ischemia‐modified albumin levels were evaluated and compared between groups. RESULTS: A total of 79 children and 74 adults were evaluated in the present study, including 46 children and 40 adults with COVID‐19, 33 healthy children, and 34 healthy adults. TT, NT, and disulfide levels were significantly lower in the adult COVID‐19 group than in all other groups (p = .001, p = .001, and p = .005, respectively). Additionally, TT and NT levels were significantly lower in both pediatric and adult COVID‐19 cases with severe disease course than mild/moderate course. TT and NT levels were identified as predictors for the diagnosis of the adult COVID‐19 cases and as independent predictors for disease severity in both children and adults with COVID‐19. CONCLUSION: Parameters that reveal the oxidant and antioxidant capacity, including TT and NT, appear to be good candidates for the accurate prediction of the clinical course among patients with COVID‐19. The current coronavirus disease 2019 pandemic is the most devastating global disease experienced in a century, and, unfortunately, its clinical manifestations, pathogenesis, and treatment remain unclear. 1, 2 The clinical course of this disease has ranged from asymptomatic to severe pneumonia and death. Additionally, the course of the disease differs in children and adults, and we are currently unable to predict the future prognosis of patients at the time of diagnosis. 3 Therefore, an in-depth understanding of the disease pathogenesis of the disease is necessary to predict the occurrence of severe pneumonia, identify potentially critical patients, develop appropriate treatments, and reduce hospitalization rates and mortality. Oxidative stress may be a key player in COVID-19 pathogenesis because it plays a significant role in the response to infections. 4 Studies have demonstrated that oxidative stress regulates the host immune system in viral diseases, such as hepatitis B, hepatitis C, herpes simplex virus, and influenza. [5] [6] [7] [8] Additionally, oxidative stress can contribute to the pathogenesis of several lung diseases in children, such as pneumonia, asthma, acute bronchiolitis, cystic fibrosis, acute respiratory distress syndrome, and chronic neonatal lung disease. [9] [10] [11] Reviews have reported a potential link between oxidative stress and the pathogenesis, severity, and mortality risk of patients infected with severe acute respiratory syndrome coronavirus (SAS-CoV). 4, 12, 13 However, to the best of our knowledge, no clinical study has been performed in children with COVID-19 to investigate the oxidant and antioxidant stress parameters. Several antioxidants can be measured in laboratories. Thiols are the main element of antioxidant defense system and good indicator of the cellular redox. 14 Additionally, thiols participate in cellular proliferation, apoptosis inflammation and immune response. 15 Total antioxidant status (TAS) and total oxidant status (TOS) are used to estimate the overall antioxidant status and oxidation state of the body. 16, 17 Another marker is ischemia-modified albumin (IMA) that has great potantial as a biomarker of oxidative stres and pneumonia. 18, 19 Because we suspected a potential relationship between oxidative stress and COVID-19, in this study, we evaluated the oxidant and oxidative stress statuses in both children and adults with COVID-19 compared with health controls and examined the use of oxidative stress parameters as a predictor of disease severity. We conducted a prospective cohort study including patients diagnosed with COVID-19 between April 10, 2020, and August 10, 2020, who were admitted to University of Health Sciences, Ankara The severity of adult cases was defined according to the criteria found in the World Health Organization interim guidelines. 21 The analysis of thiol/DD levels was performed as described by Erel and Neselioglu, using a method based on the reduction of DD bonds into reactive thiol groups in the presence of NaBH 4 . 22 Serum TAS and TOS levels were measured using automated colorimetric measurement methods, as described by Erel. 16, 17 Serum IMA levels were measured using a colorimetric assay previously described by Bar-Or et al. 23 All statistical analyses were performed using SPSS, version 19.0 (SPSS, Inc.), and a trial version of Medcalc statistical software. Descriptive statistics were used to summarize the participants' baseline characteristics, as the median and interquartile range (IQR) for continuous variables and as frequency distributions for categorical variables. The student's t test was used to compare continuous variables with a normal distribution, whereas the Mann-Whitney U test was applied to comparisons of nonnormally distributed variables. Cut-off values used to distinguish between the case and control groups were determined using receiver operator characteristic (ROC) analysis, after which the sensitivity and specificity were calculated. Two-tailed tests were used for all analyses, and p < .05 was considered significant. Figure 1A) . The calculated cut-off values for TT and NT used to distinguish adult COVID-19 patients were 379 and 420 µmol/L, respectively, which resulted in sensitivities of 58% and 58% and specificities of 82% and 82%. The AUC (95% CI) values were 0.701 (0.58-0.822) for NT and 0.699 (0.578-0.82) for TT (p = .003 and p = .003, respectively, Figure 1B) . We further analyzed whether these oxidant/antioxidant stress parameters could be used to predict COVID-19 disease severity. Adult and pediatric patients were separately divided into a severe group, which contained all severe and critically ill cases, and a nonsevere group, which included both mild and moderate cases. The ROC curves for TT and NT were calculated separately for children and adults. The results for children showed that the AUC values were 0.889 for NT and 0.885 for TT (p = .001 and p = .001, respectively, Figure 1C ). The results for adults showed that the AUC values were 0.707 for NT and 0.705 for TT (p = .002 and p = .002, respectively, Figure 1D ). We found that TT and NT levels were significantly lower in both pediatric and adult COVID-19 cases with severe disease course in the present study. Our findings supported the potential utility of using thiol levels as a predictor of COVID-19 severity, and the higher thiol levels observed in mild or moderate cases may serve as an indirect indicator of the improved antioxidant status in lung tissues due to better control of the proinflammatory processes in the lungs. 24 Additionally, our data showed that the TT and NT levels were lower in adults than in children with COVID-19, and these levels appeared to be good predictors of COVID-19 diagnosis, particularly among adults. The better thiol/DD balance observed in children might indicate they might are better protected from the harmful effects of oxidative stress than adults. Although severe patients presented with low thiol levels in both groups, the milder clinical course that is generally observed in children might be explained by these differences in the oxidative statuses of pediatric and adult cases. The imbalance between oxidant production and antioxidant mechanisms is referred to as oxidative stress and can result in oxidative damage caused by the peroxidation of lipids and the oxidation of DNA. 11 Reactive oxygen species (ROS) are produced by activated inflammatory cells in response to infectious diseases. 25 Viral infections have been found to be associated with a decreased antioxidant defense, in addition to increased neutrophil infiltration and ROS release. 26 The high neutrophil to lymphocyte ratio observed in severe COVID-19 cases, 27 the neutrophilic infiltration of pulmonary capillaries, and the increase in neutrophil activation, including the circulation of neutrophil extracellular traps, have all been suggested to serve as indicators of COVID-19. 28, 29 Thiols are major total body antioxidants that play crucial roles against ROS, protecting against damage induced by free radicals, and thiol levels decrease during the neutralization of ROS in cases of high levels of oxidative stress. 30, 31 Consistent with our findings, relative to those in healthy individuals, the TT and NT levels have been reported to be reduced during many infectious/inflammatory processes, such as acute tonsillopharyngitis, meningism, meningitis, acute appendicitis, Crimean-Congo hemorrhagic fever, and brucellosis. [32] [33] [34] [35] [36] Moreover, in an unpublished study performed at our center, thiol levels were found to be To gain entry into human cells, a spike glycoprotein on the viral envelope of SARS-CoV-2 interacts with the ACE2 receptor, which is expressed in various human organs. Therefore, the spike glycoprotein appears to represent a promising potential target for the development of specific drug treatments and vaccines. 41 Due to the urgent necessity of identifying effective anti-SARS-CoV-2 therapeutic agents, the typical drug development process may require too much time; therefore, a focus on the potential use of currently Food and Drug Administration (FDA)approved drugs might represent a reasonable therapeutic approach. Disulfiram (DSF), which is a thiol-reacting FDA-approved drug, appears to be an acceptable candidate drug that is often used over the long term by patients with chronic alcoholism. 42, 43 Recently, DSF was determined to serve as an inhibitor of the papain-like proteases associated with SARS- Several limitations of this study should be noted. First, the sample sizes were relatively small; therefore, our result cannot be generalized and require confirmation in a larger cohort to reveal the actual disease nature. Second, the detailed analyses of many of the oxidant and antioxidant parameters mentioned in the literature could not be performed in this study or linked with the disease course. For instance, the decreased expression of the antioxidant enzyme superoxide dismutase 3 (SOD3) in the lungs of a COVID-19 patient was associated with disease severity. 45 However, we believe that the findings of our study will be able to guide physicians and improve our understanding of the potential physio-pathological pathways involved in COVID-19. In conclusion, serum oxidant and antioxidant stress parameters could change in response to disease severity in COVID-19 patients. We found that serum TT and NT levels might serve as World Health Organization (WHO): Coronavirus disease (COVID-19) outbreak situation Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition) Epidemiological characteristics of 2143 pediatric patients With 2019 coronavirus disease in China Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection Oxidative Stress, Cell Activation and Viral Infection Oxidative stress and antioxidants in hepatic pathogenesis HSV infection induces production of ROS, which potentiate signaling from pattern recognition receptors: role for S-glutathionylation of TRAF3 and 6 HSV infection induces production of ROS, which potentiate signaling from pattern recognition receptors: role for S-glutathionylation of TRAF3 and 6 Oxidant and antioxidant balance in children with bacteremia Oxidants and the pathogenesis of lung diseases Impact of oxidative stress on lung diseases Oxidative stress associated with SARS-Cov-2 (COVID-19) increases the severity of the lung disease-a systematic review Can the oxidative stress index predict the severity of COVID-19? EJMED Immune system and thiols: some peculiarities of thiol exchange Extracellular thiols and thiol/disulfide redox in metabolism A new automated colorimetric method for measuring total oxidant status A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation A novel biochemical marker for community-acquired pneumonia: ischemia-modified albumin Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin The Coronavirus Scientific Advisory Board (Turkey) Clinical management of COVID-19: interim guidance A novel and automated assay for thiol/disulphide homeostasis A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report Changes in oxidative stress from tracheal aspirates sampled during chest physical therapy in hospitalized intubated infant patients with pneumonia and secretion retention. Ther Clin Risk Manag Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi Tissue damage from neutrophilinduced oxidative stress in COVID-19 The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: a retrospective study in Suzhou China Targeting potential drivers of COVID-19: neutrophil extracellular traps Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease Redox modifications of protein-thiols: emerging roles in cell signaling The significance of thiol/ disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis Alteration of thiol-disulphide homeostasis in acute tonsillopharyngitis Total antioxidant/ oxidant status in meningism and meningitis A novel oxidative stress mediator in acute appendicitis: thiol/disulphide homeostasis Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 FDAapproved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes Is low alveolar type II Cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? Evaluation of dynamic thiol/disulfide redox state in communityacquired pneumonia Oxidant and antioxidant balance in patients with COVID-19 The authors declare that there are no conflict of interests. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.